BFEC
DNA icon

Benjamin F. Edwards & Company’s Ginkgo Bioworks DNA Stock Holding History

Benjamin F. Edwards & Company’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$79K Buy
5,871
+5,527
+1,607% +$165K ﹤0.01% 1193
2024
Q1 		$16K Buy
+344
New +$17.8K ﹤0.01% 1581

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Benjamin F. Edwards & Company's DNA Position: Q2 2024 in Review

Benjamin F. Edwards & Company increased its Ginkgo Bioworks (DNA) stake by 1,607% in Q2 2024, buying an estimated $165K and bringing the position to 5,871 shares worth $79K. The position accounts for ﹤0.01% of the portfolio, ranked #1193.

Benjamin F. Edwards & Company first reported a position in DNA in Q1 2024 and has held it in 2 quarters since. 313 funds tracked by Wall St. Rank hold DNA as of Q2 2024.

  • Benjamin F. Edwards & Company held 5,871 shares of Ginkgo Bioworks worth $79K as of Q2 2024.
  • Benjamin F. Edwards & Company bought 5,527 Ginkgo Bioworks shares in Q2 2024, an estimated $165K.
  • Ginkgo Bioworks made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #1193 holding.
  • Benjamin F. Edwards & Company first reported a position in Ginkgo Bioworks in Q1 2024 and has held it in 2 quarters since.
  • 313 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.